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What this study adds 
Vascular surgery patients are predominantly elderly, often have significant 
comorbidity and are more likely to be frail. This study highlights that increasing 
severity of frailty in a cohort of vascular surgery patients is associated with poor 
outcomes at 5 years.  
Structured Abstract 
Objective: Frailty is a multi-dimensional vulnerability due to age-associated decline. 
We assessed the impact of frailty on long-term outcomes in a cohort of vascular 
surgical patients. 
Methods: Patients aged over 65 years with length of stay (LOS) > 2 days admitted to 
a tertiary vascular unit over a single calendar year were included. Demographics, 
mode of admission, diagnosis were recorded alongside a variety of frailty-specific 
characteristics. Using the previously developed Addenbrookes Vascular Frailty Score 
(AVFS – 6 point score: anaemia on admission, lack of independent mobility,  
polypharmacy , Waterlow  score > 13,  depression and emergency admission) we 
assessed the effect of frailty on 5-year mortality and readmission rates using 
multivariate regression techniques. We further refined the AVFS to assess longer term 
outcomes.  
Results: In total, 410 patients (median age 77 years) were included and followed up 
until death or five years since the index admission. One hundred and thirty-four were 
treated for aortic aneurysm, 75 and 96 for acute and chronic limb ischaemia 
respectively, 52 for carotid disease and 53 for other pathologies. The in-hospital 
mortality rate was 3.6%. The 1-, 3- and 5-year survival rates were 83%, 70% and 59% 




respectively. Independent predictors of 5-year mortality were age, lack of independent 
mobility, high Charlson score, polypharmacy, evidence of malnutrition and 
emergency admission (P<0.01 for all).   
Patients with AVFS 0 or 1 had restricted mean survival times which were 1 year 
longer than those with AVFS 2 or 3 (P<0.0001), who in turn had restricted mean 
survival times over 1 year longer than those with AVFS of 4 or more (P<0.0001). 
Conclusions: Frailty factors are strong predictors of long-term outcomes in vascular 
surgery. Further prospective studies are warranted to investigate its utility in clinical 
decision-making. 
 





The population throughout the Western world is aging and will continue to do so 
through the first half of the twenty-first century1. It is estimated that the proportion of 
the population aged over 60 will reach 33% by the year 2050.1,2  
As people age, their burden of chronic disease inevitably increases, leaving them with 
less physiological reserve to overcome the acute physiological stress encountered 
following surgical intervention. Yet advances in both surgical and anaesthetic practice 
mean that the physiological impact of surgery is reduced. For example, procedures 
that were historically contemplated in only fitter patients (eg. abdominal aortic 
aneurysm (AAA) repair), can now be undertaken in older patients with significantly 
increased comorbidity3.  
The concept of frailty, defined by some as a multi-dimensional vulnerability due to 
age-associated decline in physiological reserve, is therefore of increasing interest to 
surgeons4,5 and specifically vascular surgery, with around 60% of vascular surgical 
patients older than 65 6-8.  There is increasing evidence of the deleterious effect of 
frailty specific factors on short term outcomes yet the advent of minimally invasive 
interventions and an improvement in the management of allied chronic comorbidities 
means that older vascular surgery patients increasingly have a longer life expectancy9.   
It is therefore timely to start to focus on the longer-term effects of frailty and to try 
and identify patient subgroups who have continuing poorer health outcomes. Given 
that the concept of frailty and its role in outcomes in surgical cohorts is still somewhat 
new there is a lack of robust data on the longer-term consequences of frailty 
characteristics across the surgical subspecialties. Such data would allow for better 
allocation of resources to the neediest, highlighted by recent review of vascular 




frailty score – the Addenbrookes Vascular Frailty Score (AVFS) – which showed 
strong predictive power for outcomes including 1-year mortality rates, discharge to a 
care institution and prolonged length of stay9.  
As such, the aim of this current study was to determine the predictive effect of the 
AVFS to assess longer term (5 year) outcomes in the same cohort of vascular surgical 
patients that have been previously followed up for only one year.  Secondly, we were 
interested in determining whether other frailty specific characteristics were more 
predictive of poorer outcomes.  With this in mind, we measured a large number of 
frailty relevant characteristics and used statistical techniques to select the best 
predictors. The primary outcome measure was mortality at five years from the start of 
the index admission.  Secondary outcomes were total readmission rates and 






All patients admitted to the Cambridge Vascular Unit during the period 1st January 
2012 to 31st December 2012 were screened for inclusion in the study. The inclusion 
criteria were patients aged ≥ 65 years and those with a length of stay ≥ 2 days. These 
were chosen pragmatically in order to focus attention on a subset of patients who 
were more likely to suffer a degree of frailty, admitted with conditions that were more 
likely to be associated with a significant risk of adverse outcomes.  A full description 
of initial data collection has previously been published9.   
Patient demographics, mode of admission (elective or emergency, which was defined 
as an unplanned admission either from an outpatient clinic, through the emergency 
department or an interhospital transfer), diagnosis and management were recorded, 
along with frailty-specific characteristics. These frailty specific characteristics are 
recorded and defined where appropriate in Table 14. Need for readmission and 
survival were determined for the 5-year period from the date of the index admission.  
Vascular services are delivered using a “hub and spoke” model within our vascular 
surgery network with all vascular surgery in-patient admissions occurring at the hub 
hospital.   In order to accurately capture re-admissions, the electronic hospital records 
at all spoke hospitals were interrogated specifically for all readmissions over a 5-year 
period following the index admission. 
 
Addenbrookes Vascular Frailty Score 
Frailty was determined by scoring all patients using the Addenbrookes Vascular 




The AVFS is a 6 point score based on the following variables - anaemia on admission 
(Haemoglobin less than 120 g/L), lack of independent mobility, polypharmacy 
(defined as more than eight regular medications), a Waterlow score greater than 13, a 
history of depression and an emergency admission. This score has been previously 
shown to be predictive of one-year mortality in this cohort of vascular surgery 
patients9. 
Statistical analysis 
The impacts of frailty on survival and readmissions were investigated using both 
univariate and multivariate regression modelling for all quantities of interest.  Data on 
short-term outcomes (prolonged LOS, discharge destination, and inpatient healthcare-
related cost) have previously been reported.9  P-values for univariate analysis were 
corrected for multiple testing using the Bonferroni-Holm method10. Optimal 
multivariate models were developed by performing stepwise minimisation of 
Akaike’s Information Criterion11 and fine-tuned by then removing terms with Wald P-
values greater than 0.1. 
For survival and readmission-free survival, univariate P-values were calculated using 
the log-rank test, while multivariate analysis made use of Cox regression analysis12.  
Receiver operating characteristic curve analysis13,14 was used to assess the ability of 
frailty scores to predict 5-year survival and readmission-free survival, and 
bootstrapping with 2000 replicates was used to estimate confidence intervals and 
compare the discrimination of different frailty scores.  The ability of frailty scores to 
divide patients into low, intermediate and high-risk groups according to restricted 




Analysis was performed using the R statistical software version 3.5.1 (The R 
Foundation for Statistical Computing, http://www.r-project.org/foundation)15 together 





There were nine-hundred and forty-seven admissions to the Vascular Unit between 1st 
January 2012 and 31st December 2012, involving 823 patients. Five-hundred and 
sixty-one patients were more than 65 years old on their first admission to the unit, of 
whom four-hundred and thirteen patients had a length of stay greater than or equal to 
2 days, and therefore met both of the inclusion criteria (Figure 1).  The median age of 
this reduced cohort was 77 (range 65 – 95) years. Data was incomplete for three 
patients, so these were excluded from the analysis.  Weight, BMI and serum albumin 
were not available for a significant number of patients and so were excluded from the 
multivariate analysis, but data on the remaining parameters was available for each 
patient. 
Out of 410 patients analysed on the day of the index admission, 60 had an AVFS 
score of zero, 104 had a score of one, 93 had a score of two, 74 had a score of three, 




All patients were followed up to time of death or to 5 years post index admission. The 
in-hospital mortality rate was 3.6% during the index admission. Survival rates at 1, 3 
and 5 years were 83%, 70% and 59%, respectively. A number of the frailty specific 
characteristics that were assessed (Table 1) were significantly associated with long-
term patient survival at 5 years (Table 2).  Multivariate analysis of all the frailty 
specific characteristics revealed that six factors - patient age, lack of independent 




and emergency admission - were independent predictors of poor survival (Table 2). 
These six factors were combined to form a new frailty score specific for longer term 
outcomes – the Longer term Addenbrookes Vascular Frailty Score (LAVFS), with 1 
point for each of the six factors.  
We then compared the AVFS and LAVFS with specific to 5-year mortality rates.  
The AVFS remained a good tool for stratifying patients according to their long-term 
survival (C-statistic 0.756 at 5-years, 95% C.I. 0.709–0.802; Figure 2).   Patients with 
AVFS 0 or 1 had restricted mean survival times which were 1 year longer than those 
with AVFS 2 or 3 (mean difference 12.1 months, 95% C.I. 8.2—16.1 months, 
P<0.0001), who in turn had restricted mean survival times over 1 year longer than 
those with AVFS of 4 or more (mean difference 17.1 months, 95% C.I. 10.8—23.3 
months, P<0.0001). 
The LAVFS identified as significant independent predictors of long-term survival 
shown in table 2 also stratified patients well into groups (Figure 2b) and had 
improved discrimination when predicting long-term survival when compared to the 
AVFS (C-statistic 0.789 at 5-years, 95% C.I. 0.764–0.832, P=0.028 for improved 
discrimination over the AVFS - Figure 3).  The LAVFS also divided patients into 
distinct survival groups. Patients with LAVFS 0 or 1 had restricted mean survival 
times which were almost 1 year longer than those with AVFS 2 or 3 (mean survival 
difference 10.7 months, 95% C.I. 6.8—14.6 months, P<0.0001), who in turn had 
restricted mean survival times over 1 year longer than those with LAVFS of 4 or more 





Over the five years following the index admission, the majority (70%) of patients 
were readmitted, often multiple times.  The median number of readmissions was 2 
(IQR 0–4), with one patient re-admitted 23 times.  In total, the 410 patients were 
readmitted for 9665 days during the five years following their index admission 
(approximately 24 days per patient).  Slightly more than half of these were in the 
vascular hub (5411 days), with a smaller proportion in spoke hospitals (4254 days).  
Of the 298 patients for whom the hub was not their local hospital, 4209 admission 
days were in the spoke hospital, with only 1989 days in the Vascular hub (32%), with 
180 (60%) patients not readmitted to the hub within 5 years of their index admission. 
The vast majority (8078; 84%) of readmission days were associated with unplanned 
readmissions. 
Readmission-free survival 
At 1-, 3- and 5-years, the readmission-free survival was 48%, 28% and 21% 
respectively. Frailty characteristics were again associated with poor readmission-free 
survival (Table 3).  Multivariate analysis revealed that advanced age, poor mobility, 
multiple comorbidities, polypharmacy, emergency admission and having had a limb-
related admission were independent predictors of readmission or death (Table 3). 
The AVFS was a good discriminator of re-admission-free survival in the 5-year 
follow-up period (C-statistic 0.66, 95% C.I. 0.59-0.72), stratifying patients well into 
different risk groups (Figure 4).  The LAVFS had similar discrimination (C-statistic 
0.69, 95% C.I. 0.63-0.75, P=0.131 for improved discrimination over the AVFS). 
The AVFS divided patients into distinct low, intermediate and high risk groups with 
respect to restricted mean readmission-free survival time, with low-risk patients 




C.I. 5.5—15.4 months) longer than intermediate-risk patients (scores 2 or 3), which 
were on average 9.5 months (95% C.I. 4.6—14.3 months) longer than high-risk 
patients (score 4 or more).  Results were similar for the LAVFS. 
 
Discussion 
This study is the first to look at the longer-term effects of frailty in a group of vascular 
surgery patient. It confirms that increasing degrees of frailty predict longer term 
patient relevant outcomes, namely risk of death and readmission free survival, in a 
cohort of vascular surgery inpatients. Further, this study shows that the AVFS 
continues to be a strong predictor of poor patient outcomes out to 5 years.  
Continuing improvements in the management of both acute medical emergencies and 
chronic diseases has naturally resulted in patients living longer but at the cost of 
increasing numbers of patients with an increasing plurality of significant 
comorbidities. This is very pertinent to vascular surgery patients. Further, such aging 
of the population has also resulted in an increase in the prevalence of both mental and 
physical impairment, including both dementia and frailty19.   
Advances in technology have meant however, that we have an increasing repertoire of 
minimally invasive techniques to treat vascular conditions. Given this, as vascular 
surgeons we increasingly face challenges in clinical decision making in this specific 
demographic group of patients. As such, it is essential to reliably stratify the outcomes 
of such elderly and frail patients.  
Our previous publication showed that frailty, defined as a multifactorial medical 
syndrome characterised by reduced physiologic function and increased vulnerability 




mortality, length of stay and discharge destination all out to one year9. Such findings 
are also replicated across a number of other medical and surgical specialities. Yet, the 
vast majority of published surgical studies on frailty focus on short term effects 
predominantly out to one year 20-1. By comparison, few studies have looked at the 
effect of frailty on longer term outcomes in surgical patients. Two studies have 
reported 5-year mortality rates in older surgical patients following kidney transplant 
and patients treated for colorectal cancer and Makhani et al reported on 4-year 
survival in a cohort of frail patients predominantly undergoing urological procedures 
22-24. All of these studies showed that frailty continues to have a significant impact on 
mortality with regard to mid- and longer-term outcomes. This study offers a slightly 
different perspective in that it includes a cohort of patients admitted to the vascular 
surgery department including patients undergoing operative (open and endovascular) 
and non-operative intervention. 
Increasing frailty predicts longer term mortality in our mixed cohort of vascular 
surgery patients with a 5-year mortality rate of 59% – worse than a number of 
common malignancies. Our previously developed AVFS continues to be a strong 
predictor of mortality.  It effectively divides patients into high, intermediate and low 
risk groups, with patients in a lower risk group surviving on average over a year 
longer than those in a higher group.  It also continues to provide focus on potential 
reversible factors – anaemia, poor mobility, polypharmacy, depression and nutrition. 
Reworking the analysis focusing purely on 5-year mortality provides us with a 
slightly different scoring system – namely the LAVFS. Within this, there are a 
number of common factors from both scores (emergency admission, polypharmacy, 
mobility, nutrition) with the main difference between the scores being the significance 




perhaps unsurprising when one considers more longer-term outcomes but continues to 
highlight the potential benefits here of early involvement of specialists with an 
interest in frailty, namely medicine for the elderly physicians.  
Not only would such intervention potentially reduce the mortality risk but it is also 
likely to reduce the risk of readmission. There is an increasing recognition of the role 
of geriatricians in the management of surgical patients. This is probably best delivered 
using the concept of comprehensive geriatric assessment (CGA), a multidimensional 
holistic assessment of an older person which considers health and wellbeing and 
ultimately leads to the formulation of a plan to manage issues of concern to the older 
patient and where relevant their family and caregivers.   
The positive effect of CGA is evident in patients admitted for elective vascular 
surgery and has been shown to result in a shorter length of stay, lower incidence of 
complications and less likelihood of discharge to a higher level of dependency25.  
No data yet exists looking at the effect of comprehensive geriatric assessment in non-
elective admissions, yet it is likely that the positive effect will be even greater than 
that seen in the elective setting although whether CGA at an index admission would 
have long term effects would need further investigation. It would be valuable to see 
the effect of a community geriatrics / frailty team which would provide focused frailty 
specific interventions and as such the AVFS could identify the “at risk” cohort. This 
would link in with the longer term aim of delivering more care within the community 
and there is no doubt that more community based vascular care could dovetail well 
with this sort of community frailty team. As the population ages this will become 
more pressing to prevent unnecessary admissions to hospital. 
This study also emphasises the significant comorbidity seen in vascular surgery 




were readmitted over the 5-year follow-up period, equating to a total of 9665 days or 
24 days per patient, with the majority of these being unplanned admissions. The high 
rate of readmissions in vascular surgery patients has been highlighted in the recent 
Getting It Right First Time (GIRFT) report for vascular surgery published in the UK 
last year 26. GIRFT is part of a nationally driven deep dive of all medical and surgical 
specialties in each hospital within the UK to identify areas of good practice and areas 
for improvement. A key recommendation from this report focused on working to 
reduce avoidable readmissions by improving perioperative care and follow up 
including close liaison with medical specialties and early engagement with patients 
post-operatively. While this report focused primarily on the early period post 
discharge, the results from this study would further highlight the potential need for 
such early engagement with this cohort of patients which may provide benefit for 
patients in the longer term.  
The GIRFT report also reflects on the possible benefits for continued centralisation of 
vascular services to create a critical mass of surgeons in the hub hospital allowing 
provision of a more comprehensive service to patients. This is acutely pertinent to the 
provision of vascular surgery services within the UK but may also reflect models of 
care in other countries.  
Unlike other frailty scores, the AVFS is specific for a vascular surgery cohort and can 
be calculated based on the admission medical and nursing assessments. There a 
number of more generic frailty scores including the Clinical Frailty Scale (CFS) of the 
Canadian Study on Health & Aging. The fact that there are numerous frailty scores 
available highlights the complexity around the true definition of frailty and that frailty 
may represent variable issues in different disease groups. Indeed, the fact that there is 




fits all. The AVFS (LAVFS) is is the first vascular specific tool developed yet it is 
likely that when we analysis patient cohorts that  a combination of both a generic 
frailty score and a more disease specific tool may allow for  cross comparison 
between disease groups but also allow the sensitivity  to identify the frailty specific  
nuances associated with  that condition. This is akin to the role of questionnaire 
quality of life assessment. 
Such markers of frailty vary considerably and there are inconsistencies with regards 
to what is measured across the components of frailty including mobility / balance, 
nutrition and cognitive function. The methodological process that has led to the 
development of the AVFS and the LAVFS means that multiple domains associated 
with frailty have been assessed. Comparison between the AVFS and more commonly 
used generic frailty scores will enhance the validity of the AVFS.  
The results presented in this study help fill the current gap in knowledge on the 
longer-term effects of frailty on patients who are admitted under the care of vascular 
surgeons.  
The exclusion criteria were determined to avoid the inclusion of patients admitted 
overnight for observation after minor procedures such as angioplasty or varicose vein 
treatments, as well as to concentrate on frailty as an age-associated decline. This also 
meant that those patients who died within 48 hrs of admission were excluded. This 
consisted mainly of patient with a ruptured AAA (n=4), patients with acute limb 
ischaemia (n=3), one patient with trauma and then 4 other patients with a mixture of 
presentation.   This number is very small and therefore also of little statistical 
significance.  We are happy that the dataset we have used is robust and those data 
points that did not have complete data were excluded from analysis. The accuracy of 




but we have no reason to question that accuracy. Further while we identified all 
readmission to hospitals within our own vascular network, we are unable to determine 
whether any of this cohort of patients were admitted to hospitals outside our network 
although we feel that the numbers if any would be small and unlikely to affect the 
overall results or conclusions. We also need to be wary that in those with CLTI, 
independent mobility may be limited more by the presenting cause rather than more 
general comorbidity. Subgroup analysis with regard to admission diagnosis was not 
possible because the number of patients in each group was too small. It is known that 
infrainguinal revascularization for severe limb ischaemia contributes to poor 




In conclusion, this study demonstrates that frailty has significant effects on multiple 
key outcomes for vascular surgical patients. As the population continues to age, 
improving our understanding of the relationship between frailty and outcomes in 
surgical patients is critical as it informs decision making by the clinicians. We believe 
that future work in the field should focus on continuous re-validation of tools which 
we use for assessing frailty and using these to identify correctable patients’ factors to 
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Captions for Figures 
Figure 1: Diagrammatic representation of all patients included and excluded in the 
study. 
Figure 2: Cumulative Kaplan-Meier five-year survival estimates  stratified by (a) 
Addenbrookes Vascular Frailty Score (AVFS) and (b) Long-term Addenbrookes 
Vascular Frailty Score (LAVFS).  Patients with scores of 5 or 6 have been combined 
into a single group as there were very few patients with a score of 6. 
Figure 3: Receiver Operator Curve (ROC) curves for Addenbrookes Vascular Frailty 
Score (AVFS) and long-term AVFS (LAVFS) showing 5-year survival 
discrimination. 
Figure 4: Cumulative Kaplan-Meier five-year readmission-free survival stratified by 
Addenbrookes Vascular Frailty Score (AVFS). Patients with scores of 5 or 6 have 






Captions for Tables 
Table 1: Frailty characteristics of patients assessed with the study. Laboratory 
measurements such as serum albumin were based on samples taken within 12 hours of 
admission to hospital. If multiple samples were available, the first was used.  All of 
the remaining items are routinely documented on admission as part of the standard 
medical and/or nursing proforma in our institution. CCI: Identifies 22 comorbid 
conditions, and assigns them a score of 1, 2, 3, or 6, depending on the risk of dying 
associated with each one. Scores are summed to provide a total score. Clinical 
conditions and associated scores are as follows: 1 each: Myocardial infarct, 
congestive heart failure, peripheral vascular disease, dementia, cerebrovascular 
disease, chronic lung disease, connective tissue disease, ulcer, chronic liver disease, 
diabetes. 2 each: Hemiplegia, moderate or severe kidney disease, diabetes with end 
organ damage, tumour, leukaemia, lymphoma. 3 each: Moderate or severe liver 
disease. 6 each: Malignant tumour, metastasis, AIDS. 
Table 2: Predictors of long-term survival on univariate and multivariate analysis.  
ITU, intensive treatment unit; Hb, haemoglobin. *Significant at 1-percent level after 
Bonferroni–Holm correction. †Significant at 5-percent level after Bonferroni–Holm 
correction.  ‡Log rank test. §Wald P-value for predictor; these six significant factors 
form the Long-term Addenbrooke’s Vascular Frailty Score. 
Table 3: Predictors of long-term readmission-free survival on univariate and 
multivariate analysis.  ITU, intensive treatment unit; Hb, haemoglobin. *Significant at 






Table 1.  
 
Frailty domain Characteristic Definition/Source of data 
Comorbidity Number of medicines on 
admission 
Number of medications documented in the 
admission clerking 
Charlson comorbidity index 
(CCI) 29 
Charlson comorbidity index (not including 
points for age) calculated on admission 
Anaemia Haemoglobin concentration less than 
11.9g/dL 
Physical function Katz score30 Katz score calculated on admission. The 
score looks at 6 aspects of function and 
defines them as either dependent or 
independent. The 6 aspects are bathing, 
dressing, toileting, transferring, continence 
and feeding. This provides a score from 0 
(very dependent) to 6 (independent).  
Pre-admission mobility Mobility as documented on admission 
(Mobilises independently, mobilises with 
walking aids, dependent on others). 
Nutrition Waterlow score31 
Waterlow score calculated on admission. 
This is a score to predict risk of a pressure 
sore. The following areas are assessed for 
each patient and assigned a point value. 
Build/weight for height, skin type/visual 
risk areas, sex and age, malnutrition 





Serum albumin Serum albumin 
Weight and BMI Weight (kg) and BMI as documented on 
admission. 
Evidence of malnutrition Moderate to high risk of malnutrition 
assessed using the local screening tool (a 
modification of the Glasgow Nutritional 
Screening Tool32). 
Cognition Cognitive impairment Any documented past medical history of 
dementia in medical or nursing notes. 
Depression Any documented past medical history of 
depression in medical or nursing notes or 
currently taking antidepressants. 
Geriatric syndrome History of falls History of two or more falls in the last 12 
months. 
Visual impairment History of visual impairment including 
refractive defects, visual field defects, and 
reduced peak contrast sensitivity not 
corrected by glasses on admission. 
Hearing impairment History of hearing loss or impairment in 
either or both ears, need for a hearing aid, 
or a history of deafness on admission. 
Social vulnerability Living alone Patient lives alone in an independent 





















Age ≥ 77 on 
admission 
204 (49.8) 
<0.001* 1.59 (1.16–2.20) 0.004 
Male Sex 289 (70.5) <0.001*   
Not Independently 
Mobile On Admission 
118 (28.8) 
<0.001* 2.34 (1.56–3.52) <0.001 
Lives Alone 176 (42.9) 0.019   
Katz Score < 6 93 (22.7) <0.001* 0.67 (0.43–1.04) 0.077 
Charlson comorbidity 
index > 2 
197 (48.1) 
<0.001* 2.10 (1.52–2.91) <0.001 
Depression 24 (5.9) 0.008†   
Went to ITU during 
admission 
37 (9.0) 
0.832   
Previous Surgery 313 (76.3) 0.539   













admission (> 8 
medications) 
168 (41.0) 
<0.001* 1.70 (1.25–2.31) <0.001 
Visual Impairment 38 (9.3) <0.001*   
Hearing Impairment 44 (10.7) 0.004†   
Memory Problems 25 (6.1) <0.001*   
Waterlow on 
Admission (> 13) 
175 (42.7) 




<0.001* 1.83 (1.27–2.64) 0.001 
Two or more Falls last 
12 months 
63 (15.4) 
<0.001*   
Hb On Admission (< 
11.9 g/dL) 
203 (49.5) 
























Age ≥ 77 on 
admission 
204 (49.8) 
<0.001* 1.31 (1.04–1.65) 0.020 
Male Sex 289 (70.5) 0.113   
Not Independently 
Mobile On Admission 
118 (28.8) 
<0.001* 1.28 (1.00–1.65) 0.052 
Lives Alone 176 (42.9) 0.374   




<0.001* 1.37 (1.08–1.73) 0.052 
Depression 24 (5.9) 0.181   
Went to ITU during 
admission 
37 (9.0) 
0.452   
Previous Surgery 313 (76.3) 0.535   













admission (> 8 
medications) 
168 (41.0) 
<0.001* 1.34 (1.06–1.68) 0.014 
Visual Impairment 38 (9.3) 0.314   
Hearing Impairment 44 (10.7) 0.050   
Memory Problems 25 (6.1) 0.187   
Waterlow on 
Admission (> 13) 
175 (42.7) 




0.020   
Two or more Falls last 
12 months 
63 (15.4) 
<0.001*   
Hb On Admission (< 
11.9 g/dL) 
203 (49.5) 








<0.001* 1.46 (1.16–1.83) 0.001 
 
